Fri, June 25, 2021
Thu, June 24, 2021
Wed, June 23, 2021
Tue, June 22, 2021
Mon, June 21, 2021
Sun, June 20, 2021
Fri, June 18, 2021
Thu, June 17, 2021
Wed, June 16, 2021
Tue, June 15, 2021
Mon, June 14, 2021
Sun, June 13, 2021
Fri, June 11, 2021
Thu, June 10, 2021
Wed, June 9, 2021

Joel Beatty Maintained (BPMC) at Buy with Increased Target to $123 on, Jun 17th, 2021


  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. th-increased-target-to-123-on-jun-17th-2021.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Joel Beatty of Baird, Maintained "Blueprint Medicines Corporation" (BPMC) at Buy with Increased Target from $119 to $123 on, Jun 17th, 2021.

Joel has made no other calls on BPMC in the last 4 months.



There are 4 other peers that have a rating on BPMC. Out of the 4 peers that are also analyzing BPMC, 3 agree with Joel's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • David Lebovitz of "Morgan Stanley" Maintained at Hold with Decreased Target to $101 on, Friday, April 30th, 2021
  • Brad Canino of "Credit Suisse" Initiated at Hold and Held Target at $100 on, Wednesday, March 31st, 2021
  • Peter Lawson of "Barclays" Maintained at Hold with Increased Target to $95 on, Thursday, February 18th, 2021


This is the rating of the analyst that currently disagrees with Joel


  • Michael Schmitz of "Guggenheim" Maintained at Strong Buy with Decreased Target to $110 on, Thursday, April 29th, 2021

Publication Contributing Sources